Browse Category

Dividends News 14 December 2025 - 15 December 2025

Pfizer Stock (PFE) News Today: Dividend, 2026 Guidance Call, Obesity Deals, and Analyst Forecasts (Dec. 15, 2025)

Pfizer Stock (PFE) News Today: Dividend, 2026 Guidance Call, Obesity Deals, and Analyst Forecasts (Dec. 15, 2025)

Pfizer Inc. (NYSE: PFE) enters the new week with its stock hovering around $25.85 in early Monday trading, as investors weigh a familiar late-2025 mix: a high dividend, a rebuilding growth story after the COVID boom, and a pipeline/M&A strategy designed to refill the revenue engine ahead of major patent cliffs. The immediate spotlight is tomorrow morning’s full-year 2026 guidance call—a scheduled catalyst that can reset expectations for revenue, margins, and capital allocation going into 2026. Pfizer Pfizer stock price today: where PFE stands on Dec. 15, 2025 As of 12:08 UTC on Monday, Pfizer shares traded at $25.85, essentially
HSBC Holdings Plc Stock: Hang Seng Bank Buyout Vote Nears, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

HSBC Holdings Plc Stock: Hang Seng Bank Buyout Vote Nears, Dividend Signals, and Analyst Forecasts (Dec. 15, 2025)

HSBC Holdings Plc (HSBA.L / 0005.HK / HSBC) heads into mid-December with a very “HSBC” mix of catalysts: a large, Asia-centric acquisition moving closer to a shareholder vote, upgraded profitability guidance from management, and fresh consensus estimates that map what the sell side thinks the bank can deliver through 2027. The headline on December 15 is simple: the proposed take-private of Hong Kong’s Hang Seng Bank is advancing through its formal process—important because the deal is big enough to shape how investors think about capital returns, risk exposure to Hong Kong and mainland China property, and HSBC’s strategic pivot under
Shell Plc Stock (SHEL) Today: UK Audit Probe, Buybacks, Dividend Timing, and Analyst Forecasts (Dec. 15, 2025)

Shell Plc Stock (SHEL) Today: UK Audit Probe, Buybacks, Dividend Timing, and Analyst Forecasts (Dec. 15, 2025)

Shell plc (LSE: SHEL; NYSE: SHEL) is in the spotlight on December 15, 2025, after a fresh regulatory headline in the UK revived investor focus on audit governance—at the same time the energy major continues a sizable share buyback program, approaches a near-term dividend payment date, and faces swirling speculation about portfolio moves from the Gulf of Mexico to Brazil and Southern Africa. shell.com+4Reuters+4Reuters+4 In London, Shell shares opened at 2,707p, following a previous close of 2,686.5p (Dec. 12), according to the London Stock Exchange’s company page. London Stock Exchange In the U.S., Shell’s ADR last closed at $72.33 (Dec.
Indian Oil Corporation (IOC) Share Price Today, Dec 15, 2025: Interim Dividend, Refining Margins, Russian Crude Risks and Analyst Targets

Indian Oil Corporation (IOC) Share Price Today, Dec 15, 2025: Interim Dividend, Refining Margins, Russian Crude Risks and Analyst Targets

New Delhi — December 15, 2025 Indian Oil Corporation Ltd. (IOCL) stock (NSE: IOC; BSE: 530965) is back in the spotlight heading into the second half of December, with traders and long-term investors weighing a fresh interim dividend, a stronger recent earnings backdrop, and a geopolitics-heavy crude procurement environment. By early afternoon on Monday, Indian Oil shares were trading around ₹166.60, up about 1.8% on the day, even as broader Indian equities slipped amid foreign outflows and trade-deal uncertainty. The Economic Times+1 Indian Oil share price today: IOC stock outperforms as the market turns cautious The broader tone in Indian
OCBC Stock (SGX: O39) Today: Share Price Near S$19.2 as Dividends, Buybacks and Wealth Growth Drive 2026 Debate

OCBC Stock (SGX: O39) Today: Share Price Near S$19.2 as Dividends, Buybacks and Wealth Growth Drive 2026 Debate

SINGAPORE (Dec. 15, 2025) — Oversea-Chinese Banking Corporation Limited (OCBC) stock is trading around S$19.2 in mid-afternoon Singapore time on Monday, keeping the lender’s shares close to the record-setting run seen since early November. SG Investors+1 That “near-highs” backdrop matters because OCBC’s current bull case isn’t one single headline. It’s a bundle: wealth-management momentum, a defined capital return plan (dividends + buybacks), and a leadership transition heading into 2026—set against a rate environment that management itself says is squeezing margins. Reuters+2The Business Times+2 OCBC share price on Dec. 15, 2025: still elevated after a record streak OCBC’s share price was
Macquarie Group (ASX:MQG) Stock Update — 15 Dec 2025: Share Price Moves, Dividend Countdown, Buyback, and Analyst Forecasts

Macquarie Group (ASX:MQG) Stock Update — 15 Dec 2025: Share Price Moves, Dividend Countdown, Buyback, and Analyst Forecasts

Sydney, 15 December 2025 — Macquarie Group Limited (ASX:MQG; ADR: MQBKY) entered the final full trading weeks of the year with investors juggling three big storylines at once: a near-term dividend payment, a capital-management program that can keep soaking up stock, and a debate about whether the group’s earnings engine is merely “between cycles” or structurally cooling. Macquarie On the tape, the day was mildly negative. Macquarie shares finished around A$200.2 on 15 December, down roughly 0.7%, after trading between ~A$199.38 and ~A$202.93. Investing.com Beneath that modest move is a more interesting question: what is the market paying for Macquarie
ANZ Group Holdings Limited Stock (ASX: ANZ): Share Price, Dividend, AGM Showdown and Analyst Forecasts on 15 December 2025

ANZ Group Holdings Limited Stock (ASX: ANZ): Share Price, Dividend, AGM Showdown and Analyst Forecasts on 15 December 2025

ANZ Group Holdings Limited (ASX: ANZ) is back in the spotlight in Australia’s final full trading week of the year, with investors balancing a rising share price against a busy calendar: a proposed final dividend due this Friday, and an Annual General Meeting (AGM) that’s shaping up as a high-stakes referendum on governance, accountability and execution under new CEO Nuno Matos. Reuters+3Investing.com+3ANZ+3 On Monday 15 December 2025, ANZ shares traded around A$36.22, up about 1.14% on the day, after a previous close around A$35.81, according to market data services tracking the ASX line. Investing.com+1 ANZ share price today: what’s happening
Merck stock (MRK): News, dividend date, Keytruda updates and analyst forecasts to watch before the U.S. market opens Dec. 15, 2025

Merck stock (MRK): News, dividend date, Keytruda updates and analyst forecasts to watch before the U.S. market opens Dec. 15, 2025

Merck & Co., Inc. (NYSE: MRK) heads into Monday’s U.S. session (December 15, 2025) with investors juggling a mix of near-term headlines and long-term franchise questions: a fresh dividend “reset” that makes Dec. 15 an important calendar day, ongoing scrutiny around RSV prevention products, and high-stakes execution on the company’s plan to diversify beyond Keytruda ahead of the drug’s expected loss of exclusivity later this decade. MarketWatch+2Reuters+2 Below is what to know before the opening bell. MRK stock: where shares stand heading into Monday Merck shares most recently closed at $100.30 on Friday, Dec. 12, extending a three-day winning streak
Amphenol (APH) Stock News, Forecasts and Analysis for Dec. 14, 2025: AI Data-Center Demand, Dividend Catalyst, and Wall Street Targets

Amphenol (APH) Stock News, Forecasts and Analysis for Dec. 14, 2025: AI Data-Center Demand, Dividend Catalyst, and Wall Street Targets

Amphenol (NYSE: APH) stock slid sharply on Friday amid an AI-linked selloff. Here’s what’s new on Dec. 14, 2025—filings, forecasts, analyst targets, dividend dates, and catalysts. Published: December 14, 2025 Amphenol Corporation (NYSE: APH) is back in the spotlight this weekend after a sharp pullback that hit several “AI infrastructure” names at once. The stock closed at $129.24 on Friday, Dec. 12, down 7.08%—a move that caught investors’ attention because it came even as the company has been delivering strong growth, guiding confidently, and expanding through major acquisitions. Investing On Sunday, Dec. 14, 2025, the day’s headlines around Amphenol stock
Mastercard Stock (NYSE: MA) News Today: $14B Buyback, Dividend Hike, Analyst Targets, and Key Risks (Dec. 14, 2025)

Mastercard Stock (NYSE: MA) News Today: $14B Buyback, Dividend Hike, Analyst Targets, and Key Risks (Dec. 14, 2025)

Updated: December 14, 2025 Mastercard Incorporated (NYSE: MA) is heading into the final stretch of 2025 with fresh momentum from a major shareholder-return announcement—a new $14 billion share repurchase authorization and a 14% dividend increase—while investors continue to weigh the longer-term backdrop: expanding digital payments partnerships, an evolving crypto/stablecoin strategy, and the still-unfolding implications of a massive U.S. merchant swipe-fee settlement. Mastercard Investor Relations+1 Because today is Sunday (Dec. 14) and U.S. markets are closed, the most recent price reflects the latest completed trading session. Mastercard last traded around $571.93, up about 1.5% on the day, with a market cap
JPMorgan Chase (JPM) Stock News Today: $105B 2026 Expense Outlook, Dividend Update, and Analyst Price Targets (Dec. 14, 2025)

JPMorgan Chase (JPM) Stock News Today: $105B 2026 Expense Outlook, Dividend Update, and Analyst Price Targets (Dec. 14, 2025)

JPMorgan Chase & Co. (NYSE: JPM) stock is trading near $318 after a volatile week driven by a higher 2026 expense outlook, fresh dividend details, and shifting analyst price targets. Here’s what’s moving JPM stock and what to watch into earnings. JPMorgan Chase & Co. (NYSE: JPM) heads into the second half of December with its stock near $318 a share—close to its 52-week highs—after a week that reminded investors why “best-in-class” banks can still get punished for one thing: costs. Simply Wall St The biggest catalyst was management signaling that 2026 expenses could rise to about $105 billion, well
Pfizer Stock (PFE) Outlook: This Week’s Key Headlines, Dividend Update, and What to Watch Ahead of 2026 Guidance (Updated Dec. 14, 2025)

Pfizer Stock (PFE) Outlook: This Week’s Key Headlines, Dividend Update, and What to Watch Ahead of 2026 Guidance (Updated Dec. 14, 2025)

Pfizer Inc. (NYSE: PFE) heads into the new trading week with investors balancing two very different storylines: a steady, high-yield “value pharma” profile versus a news-driven catalyst tape around obesity deals, oncology data, cost cuts, and shifting U.S. COVID-vaccine policy. As of the latest close, Pfizer shares were around $25.85. With markets closed on Sunday (Dec. 14), the next big directional test arrives quickly: Pfizer’s analyst and investor call on Tuesday, Dec. 16, where management is scheduled to provide full-year 2026 financial guidance. Pfizer+1 Below is a detailed, news-driven look at what moved Pfizer stock in recent days—and what could
1 26 27 28 29 30 55

Stock Market Today

Nebius (NBIS) stock jumps 16% into weekend as AI trade whipsaws; earnings next week in focus

Nebius (NBIS) stock jumps 16% into weekend as AI trade whipsaws; earnings next week in focus

7 February 2026
Nebius shares jumped 16.6% to $86.10 on Friday, rebounding from a 10.3% drop Thursday. The company will report fourth-quarter and full-year 2025 results before the market opens on Feb. 12. U.S. jobs and inflation data are due next week after a delay from a government shutdown. Recent swings in Nebius stock followed volatility in AI-linked tech names after Alphabet’s spending update.
Go toTop